BioSpace News Archive

Ryvu Therapeutics to Host Key Opinion Leader Webinar on RVU120 for the Treatment of Hematological Malignancies and Solid Tumors

KOL and Management to present on Monday, June 13, 2022 , @ 2:30pm ET.

June 6, 2022
·
3 min read
Bio NC

Seqirus Completes $156 Million Expansion to Holly Springs Manufacturing Facility, Optimizing Global Manufacturing Capabilities for Seasonal and Pandemic Influenza Vaccines

Seqirus, a global leader in influenza prevention and a business of CSL Limited, announced the completion of an expansion to the company’s manufacturing facility in Holly Springs, N.C., supporting the formulation and fill-finish of its cell-based influenza vaccines in pre-filled syringes for global communities.

June 6, 2022
·
10 min read